Literature DB >> 2054268

Influence of acid secretory status on absorption of omeprazole from enteric coated granules.

T Andersson1, R Bergstrand, C Cederberg.   

Abstract

1. In order to study the absorption of omeprazole under normal acidic conditions in the stomach as well as when the granules are exposed to minimal gastric acid, eight healthy males were given 20 mg omeprazole as enteric coated (EC) granules either alone or 2 h after a ranitidine dose of 300 mg, respectively. 2. Blood samples were collected at intervals for 12 h following both omeprazole administrations. The pH was recorded during the first 4 h in half the subjects in each experiment to document the difference in pH during the absorption phase of omeprazole. 3. The area under the plasma concentration-time curve, AUC, of omeprazole was virtually the same irrespective of whether or not the granules were exposed to gastric acid. However, the maximum plasma concentration (Cmax) was higher and the time to reach Cmax was shorter when omeprazole was administered after a ranitidine dose. 4. It is concluded that gastric acidity has negligible influence on the AUC of omeprazole, which is directly correlated to the antisecretory effect, when administered as EC granules.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2054268      PMCID: PMC1368353          DOI: 10.1111/j.1365-2125.1991.tb05530.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.

Authors:  B Wallmark; P Lorentzon; H Larsson
Journal:  Scand J Gastroenterol Suppl       Date:  1985

2.  The slowing of gastric emptying by nine acids.

Authors:  J N Hunt; M T Knox
Journal:  J Physiol       Date:  1969-03       Impact factor: 5.182

3.  Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell.

Authors:  B Wallmark; A Brändström; H Larsson
Journal:  Biochim Biophys Acta       Date:  1984-12-19

4.  Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects.

Authors:  T Andersson; K Andrén; C Cederberg; P O Lagerström; P Lundborg; I Skånberg
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

5.  A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers.

Authors:  K D Bardhan; G Bianchi Porro; K Bose; M Daly; R F Hinchliffe; E Jonsson; M Lazzaroni; J Naesdal; L Rikner; A Walan
Journal:  J Clin Gastroenterol       Date:  1986-08       Impact factor: 3.062

6.  Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.

Authors:  E Fellenius; T Berglindh; G Sachs; L Olbe; B Elander; S E Sjöstrand; B Wallmark
Journal:  Nature       Date:  1981-03-12       Impact factor: 49.962

7.  Determination of omeprazole and metabolites in plasma and urine by liquid chromatography.

Authors:  P O Lagerström; B A Persson
Journal:  J Chromatogr       Date:  1984-08-10

8.  [Suppression of acid secretion and plasma level of a once-daily dose of omeprazole].

Authors:  P Müller; H K Seitz; B Simon; H G Dammann
Journal:  Arzneimittelforschung       Date:  1983

9.  Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.

Authors:  T Lind; C Cederberg; G Ekenved; U Haglund; L Olbe
Journal:  Gut       Date:  1983-04       Impact factor: 23.059

10.  Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage.

Authors:  P J Prichard; N D Yeomans; G W Mihaly; D B Jones; P J Buckle; R A Smallwood; W J Louis
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

View more
  4 in total

Review 1.  Pharmacokinetic considerations in the eradication of Helicobacter pylori.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 2.  Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.

Authors:  M I Wilde; D McTavish
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

3.  Formulation and evaluation of omeprazole tablets for duodenal ulcer.

Authors:  A Choudhury; S Das; S Bahadur; S Saha; A Roy
Journal:  Indian J Pharm Sci       Date:  2010-07       Impact factor: 0.975

4.  The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.

Authors:  S Šutalo; M Ruetten; S Hartnack; C E Reusch; P H Kook
Journal:  J Vet Intern Med       Date:  2015-05-13       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.